Newsroom

Immitra Bio receives CHF 150,000 from Venture Kick to reimagine stem cell therapy for rare diseases

15.06.2026

The ETH spin-off Immitra Bio has received CHF 150,000 from Venture Kick to develop a new treatment approach for rare genetic disea ... more

PolaSight receives CHF 40,000 from Venture Kick to advance rapid tissue characterization in pathology

15.06.2026

PolaSight receives CHF 40,000 from Venture Kick to advance PolaOne, its AI-powered polarimetric imaging platform for pathology. Th ... more

Inside the Jury Room: The Founders Who Stand Out Are Usually the Best Prepared by Caroline Gueissaz

11.06.2026

A Venture Kick jury session lasts only a few minutes, but experienced investors and entrepreneurs often form their first impressio ... more

more

Media contacts

For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.

Learn more about Venture Kick or download the latest annual report for detailed information.